Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion

China's demand for hypertension treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic  |  read more...

BMI View: As a developed market, Australia represents opportunities for risk averse pharmaceuticalinvestors, given its ageing and generally affluent population. Importantly, the government is implementingcost-cutting measures to cope with escalating healthcare costs, therefore generic drugmakers  |  read more...

BMI View: We expect Namibia's negative pharmaceutical trade balance to widen as demand for medicinescontinues to be met by imports, and poor local manufacturing sees exports contract in the medium term.Headline Expenditure Forecasts Pharmaceuticals: NAD2.20bn  |  read more...

BMI View: Chile's improving regulation system should bring high quality medicines to the local marketand eventually reduce the country's medical spending. The tightened bioequivalent regulations will boostgenuine medicine sales and force similares out of the  |  read more...

BMI View: Commercial incentives for foreign drugmakers to expand in the Central Americanpharmaceutical market are limited by the region's relatively low per capita pharmaceutical spending andmarket growth. However, the heavy reliance on imported medicine in  |  read more...